Clinical Trial Update: Botswana TDF/FTC Oral HIV Prophylaxis Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials in Botswana evaluated TDF/FTC as oral HIV prophylaxis in Phase 2 and Phase 3; status completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TDF/FTC (emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: HIV Infections | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-02-05